How Weight-Loss Drugs Could Impact U.S. Healthcare and Food. Plus, the Biggest Problems With GLP1s.

How Weight-Loss Drugs Could Impact U.S. Healthcare and Food. Plus, the Biggest Problems With GLP1s.

Today’s episode is our second in a series on the weight-loss drug revolution of the last two years. On Tuesday, we talked to endocrinologist Beverly Tchang about the science of glucagon like peptide 1 receptor agonists—also known as GLP1s, also known as Ozempic, Wegovy, Moujargo, and Zepbound. If you haven’t listened to that show, I think you’ll feel safe and entertained within the bounds of this episode. But if you want to know more about how these drugs work, their effect on insulin and glucose and the brain’s reward center, or the questions they raise about obesity and the nature of willpower and free will, I’d encourage you to queue up that show. Today, in Part 2, we have two guests: Zach Reitano is the CEO and cofounder of the telehealth platform Ro. He is here for a couple reasons. He has a bird’s-eye view of the GLP1 marketplace, the rise in demand, the supply chain, the economics of pricing and insurance. He’s also written several revelatory essays, pulling in research from think tanks, medical experts, and investment banks, that have helped shape my understanding of these drugs and the effect they could have on the population and the economy. Our second guest is Dr. Robert Lustig, an endocrinologist who spent years as a pediatrician and researcher at the University of California-San Francisco. As you’ll hear, he is much less optimistic about the ability of these drugs to revolutionize obesity medication in America. If you have questions, observations, or ideas for future episodes, email us at PlainEnglish@Spotify.com. Host: Derek Thompson Guests: Zach Reitano & Robert Lustig Producer: Devon Baroldi Learn more about your ad choices. Visit podcastchoices.com/adchoices

Episoder(363)

A New Way to Think About Racism in America

A New Way to Think About Racism in America

Several years ago, the writer, researcher, and policy advocate Heather McGhee traveled around the country to report on how racism in America holds us back from policies that would benefit everybody. I...

12 Aug 202244min

Carbon Removal Might Be the World’s Most Important Technology. How Does It Work?

Carbon Removal Might Be the World’s Most Important Technology. How Does It Work?

Last year, somebody explained the problem of climate change to me with a metaphor that I’ve never been able to forget. They said: Imagine a bathtub. The bathtub is the planet’s atmosphere. The faucet ...

9 Aug 202246min

Curiosity Corner: Monkeypox Myths, Millennial Facts, and Overpopulation Fears

Curiosity Corner: Monkeypox Myths, Millennial Facts, and Overpopulation Fears

In our second "Curiosity Corner" mailbag, Derek takes your burning questions. He breaks down the myths around how monkeypox spreads, and blasts public health officials for not being more specific abou...

5 Aug 202230min

Is Old Music Killing New Music?

Is Old Music Killing New Music?

Why does it seem like the old is eating the new in pop culture? This year, the song of the summer is arguably Kate Bush’s “Running Up That Hill”—which was released in 1985. It was launched by the most...

3 Aug 202253min

How the Democrats' New Climate Bill Could Change the World

How the Democrats' New Climate Bill Could Change the World

“Every few years, American politics astonishes you.” That’s how The Atlantic journalist Robinson Meyer began his report on the Democrats' new climate deal, which would invest record-breaking sums in c...

1 Aug 202224min

Why the Question "Are We in a Recession?" Is Impossible to Answer

Why the Question "Are We in a Recession?" Is Impossible to Answer

On Thursday, the Bureau of Economic Analysis announced that GDP dropped for the second consecutive quarter, fueling fears that the economy is in a recession. Today's guest is Austan Goolsbee, a profes...

29 Jul 202239min

Crypto Crash, Part II: A Debate About the Future of Web3

Crypto Crash, Part II: A Debate About the Future of Web3

Today is the second half of our special two-parter on the state of crypto. Yesterday’s theme was the case against. Today we debate the case for. In the last few weeks, use-cases have become a popular ...

26 Jul 202254min

Crypto Crash Part I: The Case Against Crypto

Crypto Crash Part I: The Case Against Crypto

Today, we have the first in a two-part series on lessons from the crypto crash. Crypto, also known as Web3, also known as blockchain-based technologies, remains the weirdest space I’ve ever reported o...

25 Jul 202249min

Populært innen Politikk og nyheter

giver-og-gjengen-vg
aftenpodden
lydartikler-fra-aftenposten
forklart
aftenpodden-usa
popradet
stopp-verden
i-retten
dine-penger-pengeradet
fotballpodden-2
det-store-bildet
rss-gukild-johaug
nokon-ma-ga
hanna-de-heldige
rss-ness
aftenbla-bla
e24-podden
rss-dannet-uten-piano
grasoner-den-nye-kalde-krigen
frokostshowet-pa-p5